US4230617AExpiredUtility
Somatostatin analogues
Est. expiryJul 5, 1999(expired)· nominal 20-yr term from priority
Inventors:Dimitrios Sarantakis
C07K 14/655C07K 14/6555A61K 38/00Y10S930/16
48
PatentIndex Score
4
Cited by
5
References
4
Claims
Abstract
The polypeptides, <IMAGE> +TR <IMAGE> the linear precursor intermediates therefor or non-toxic acid addition salts thereof in which X2 is NH2, Ala-Gly-, Ala-D-Ala-, Gly-Gly-Gly-, lower alkanoyl or benzoyl; X4 is Arg, His, D-Arg or D-His; X5 is His, Tyr, Glu, D-His, D-Tyr or D-Glu; X7 is Trp, Tyr, Met or His; and X8 is Trp or D-Trp; inhibit the release of growth hormone and are useful in the treatment of acromegaly and diabetes.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A compound of the formula: ##STR3## its linear precursor intermediates or non-toxic acid addition salts thereof in which X 2 is NH 2 , Ala-Gly-, Ala-D-Ala, Gly-Gly-Gly-, lower alkanoyl or benzoyl; X 4 is Arg, His, D-Arg, or D-His; X 5 is His, Tyr, Glu, D-His, D-Tyr, or D-Glu; X 7 is Trp, Tyr, Met, or His; and X 8 is Trp or D-Trp.
2. The compound of claim 1 in which X 7 is Trp or His.
3. The compound of claim 1 which is [des-Ala 1 -Gly 2 ], Arg 4 , His 5 , His 7 , D-Trp 8 -somatostatin.
4. The compound of claim 1 which is [des-Ala 1 -Gly 2 ], Arg 4 , His 5 , Trp 7 , D-Trp 8 -somatostatin.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.